Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

BUY
$185.1 - $233.13 $25,543 - $32,171
138 Added 0.91%
15,226 $3.52 Million
Q3 2023

Oct 18, 2023

SELL
$233.08 - $265.59 $187,629 - $213,799
-805 Reduced 5.07%
15,088 $3.74 Million
Q2 2023

Jul 12, 2023

SELL
$224.99 - $256.14 $120,369 - $137,034
-535 Reduced 3.26%
15,893 $3.81 Million
Q1 2023

Apr 12, 2023

SELL
$239.75 - $277.0 $72,884 - $84,208
-304 Reduced 1.82%
16,428 $4.14 Million
Q4 2022

Jan 06, 2023

SELL
$241.42 - $282.29 $256,146 - $299,509
-1,061 Reduced 5.96%
16,732 $0
Q3 2022

Oct 14, 2022

BUY
$247.06 - $1507.4 $199,624 - $1.22 Million
808 Added 4.76%
17,793 $4.6 Million
Q2 2022

Jul 07, 2022

BUY
$237.11 - $299.66 $127,090 - $160,617
536 Added 3.26%
16,985 $4.31 Million
Q1 2022

Apr 27, 2022

BUY
$257.27 - $315.76 $302,549 - $371,333
1,176 Added 7.7%
16,449 $4.83 Million
Q4 2021

Jan 25, 2022

BUY
$292.08 - $329.01 $357,505 - $402,708
1,224 Added 8.71%
15,273 $5.03 Million
Q3 2021

Oct 19, 2021

SELL
$272.21 - $332.43 $341,623 - $417,199
-1,255 Reduced 8.2%
14,049 $4.28 Million
Q2 2021

Aug 02, 2021

SELL
$225.08 - $271.69 $6,752 - $8,150
-30 Reduced 0.2%
15,304 $4.11 Million
Q1 2021

Apr 16, 2021

BUY
$212.38 - $245.9 $84,952 - $98,360
400 Added 2.68%
15,334 $3.45 Million
Q4 2020

Jan 11, 2021

BUY
$212.5 - $245.46 $259,250 - $299,461
1,220 Added 8.9%
14,934 $3.32 Million
Q3 2020

Oct 22, 2020

SELL
$177.16 - $215.33 $156,786 - $190,567
-885 Reduced 6.06%
13,714 $3.11 Million
Q2 2020

Aug 03, 2020

BUY
$128.7 - $176.83 $23,423 - $32,183
182 Added 1.26%
14,599 $2.58 Million
Q1 2020

Apr 20, 2020

SELL
$121.39 - $169.05 $6,919 - $9,635
-57 Reduced 0.39%
14,417 $2 Million
Q4 2019

Feb 07, 2020

BUY
$133.47 - $153.48 $1.93 Million - $2.22 Million
14,474 New
14,474 $2.22 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Epiq Partners, LLC Portfolio

Follow Epiq Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Partners, LLC with notifications on news.